Journal article
A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
- Abstract:
-
BACKGROUND: We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis. PATIENTS AND METHODS: This was a single-blinded, randomized controlled phase II presurgical (radical prostatectomy) 28-day trial of celecoxib versus no drug in patients with localized T1-2 N0 M0 prostate cancer. cDNA microarray analysis was carried out on prostate cancer biopsies taken from freshly obtained ra...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Cancer genomics and proteomics
- Volume:
- 6
- Issue:
- 2
- Pages:
- 93-99
- Publication date:
- 2009-01-01
- EISSN:
-
1790-6245
- ISSN:
-
1109-6535
- URN:
-
uuid:cf37ed9a-da47-4811-819c-f9be1a3e660a
- Source identifiers:
-
414579
- Local pid:
- pubs:414579
Item Description
Terms of use
- Copyright date:
- 2009
If you are the owner of this record, you can report an update to it here: Report update to this record